This webinar was funded by an educational grant from Pfizer. The views and opinions expressed are those of the speakers and not necessarily of Pfizer or EMJ.
This upcoming webinar discussion shares clinical insights from an expert in the use of direct oral anticoagulants for the treatment of cancer-related venous thromboembolisms. Harry Gibbs (Melbourne Australia).
Gibbs discuss with medical correspondent Lisa Burke patient cases from their clinical experience to highlight how new treatments and trial updates have influenced their decision-making in patient-centred care.
Biographies of speakers
Harry Gibbs is the Program Director of Outpatients Program and Deputy Director of General Medicine at The Alfred Hospital, Melbourne, Australia. Gibbs is also an Adjunct Clinical Associate Professor at Monash University, Melbourne, Australia. He has worked at various centres of excellence in both Australia and the USA. His interests are in cardiovascular and general medicine, with a particular interest in thrombosis and anticoagulant therapy. In 2018, he was part of the team to win the MJA, MDA National Prize for Excellence in Medical Research. Gibbs is currently a board member of The Australian and New Zealand Society for Vascular Surgery (ANZSVS).
